← Eichor
Study identifier: NCT03965299 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Transcutaneous Tibial Nerve Stimulation in Acute Spinal Cord Injury

Condition: Spinal Cord Injury, Acute  ·  Sponsor: University of Zurich

PhaseNA
Planned participants114
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Most patients with spinal cord injury (SCI) develop neurogenic lower urinary tract dysfunction (NLUTD), one of the most devastating sequelae of SCI which ultimately can lead to renal failure. We urgently need an intervention that prevents NLUTD before irreversible damage occurs. Neuromodulation procedures are a promising avenue so that we investigate the effect of transcutaneous tibial nerve stimulation (TTNS) in patients with acute SCI. This nationwide randomized, sham-controlled, double-blind multicentre clinical trial includes all SCI centres in Switzerland (Basel, Nottwil, Sion, Zürich). Patients are randomly assigned to VERUM TTNS (active stimulation, n=57) and SHAM stimulation (n=57) groups in a 1:1 allocation using computer-generated permuted block randomisation lists stratified on study centre and lower extremity motor score. Daily 30-minute sessions are performed five times a week during an intervention period of 6-9 weeks. The primary outcome of this study is the success of TTNS to prevent neurogenic DO jeopardizing the upper urinary tract, assessed by urodynamics at 1 year after SCI or any earlier time point if DO treatment is necessary (study end). Secondary outcome measures are bladder diary parameters, clinical symptom scores assessed by standardized and validated questionnaires. Furthermore, neurophysiological and neuroimaging outcome measures are assessed as well as, biochemical and molecular changes. Tertiary outcome measure is the safety of TTNS. Before th…

This description comes directly from the study's public registry record.

Talk to the study team

Thomas M. Kessler, Prof. Dr. med.  ·  +41 44 386 39 07  ·  thomas.kessler@balgrist.ch

Martina D. Liechti, Dr. sc. ETH  ·  +41 44 386 39 07  ·  martina.liechti@balgrist.ch

Always discuss trial participation with your own doctor first.

Locations (4)

Department of Neuro-Urology, Spinal Cord Injury Centre & Research, Balgrist University HospitalZurich, Canton of Zurich, SwitzerlandRecruiting
REHAB BaselBasel, SwitzerlandRecruiting
Swiss Paraplegic CentreNottwil, SwitzerlandRecruiting
Spinal Cord Injury Department, Clinique romande de réadaptionSion, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03965299